Grovecourt Capital Partners, a private equity firm based in West Palm Beach, Florida, has acquired IMRIS Imaging, a company specializing in intraoperative MR imaging solutions.

Founded in 2005 and headquartered in Chaska, Minnesota, IMRIS develops and services intraoperative MR suites designed to improve surgical precision, particularly in neurosurgery. The company's technology features a ceiling-mounted, movable MR system that can transition between diagnostic and operating rooms, allowing imaging to take place without repositioning the patient. The system is intended to enhance surgical accuracy, minimize the need for follow-up procedures, and eliminate post-surgical MR scans.

"IMRIS stands at the forefront of intraoperative medical imaging," said Matt Bergin, managing partner at Grovecourt. "As seasoned investors in the medical imaging space, we are thrilled to partner with Marc Buntaine, Greg Sorensen, and the entire IMRIS team to drive innovation, expand the company’s products and services, and enhance patient care."
IMRIS CEO Marc Buntaine noted that the acquisition represents a key moment for the company, adding, "We are eager to expand the boundaries of intraoperative MR imaging into emerging applications, such as laser ablation and high-intensity focused ultrasound procedures."

Dr. Gregory Sorensen, executive chairman of IMRIS, echoed this sentiment, stating, "This partnership with Grovecourt will enable us to enter a new phase of growth and accelerate IMRIS’ mission to improve patient care through innovative intraoperative technologies."

Financial terms of the deal were not disclosed.

Operating Room Homepage